Brand Logo of Anderson Diagnostics
A vector illustration explaining the Oncomine Focus Assay process.

Oncomine Focus Assay

Single Panel for Testing 18 Types of Solid Tumors
KNOW MORE
Sample Type
FFPE Block or Fresh Tissue in ONCO-Bank
TAT
2 to 3 weeks

Oncomine focus

  • Hot spot screening of relevant, druggable mutations, copy number changes and fusions for various Cancers
  • Analysing of 1000 variants across 52 genes for -- cancers
  • ACMG/AMP guidelines-based reporting with drugs and target information
  • NGS based assay eliminate need of multiple technology FISH, IHC, Realtime
  • High Sensitivity and Specificity
  • Identifies druggable targets in various cancers and unknown primary
Vector image illustrates the Oncomine testing.

Workflow

The image showing the Oncomine workflow.

List of genes

SNV’s; Indels AKT1, ALK, AR, BRAF, CDK4, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR2, FGFR3, GNA11, GNAQ, HRAS, IDH1, IDH2, JAK1, JAK2, JAK3, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, PDGFRA, PIK3CA, RAF1, RET, ROS1, SMO
CNV’s AKT1, ALK, AR, BRAF, CCND1, CDK4, CDK6, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, FGFR4, KIT, KRAS, MET, MYC, MYCN, PDGFRA, PIK3CA
Fusions ABL1, AKT3, ALK, AXL, BRAF, EGFR, ERBB2, ERG, ETV1, ETV4, ETV5, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK2, NTRK3, PDGFRA, PPARG, RAF1, RET, ROS1
The image shows the list of genes in different cancer.
CENTRAL GENETIC LAB
Anderson Diagnostics and Labs,
No.26, Rajarathinam Street,
Kilpauk, Chennai - 600010.

SNV and CNV profile of oncomine focus genes in Pan-cancer data

A graph shows SNV and CNV profile of oncomine focus genes in Pan-cancer data.

All types of solid tumors showing the presence of mutation and copy number variation, in the genes present in oncomine focus assay. Hence, this assay best suited to identify druggable mutation, driver mutation or CNV changes and prognostic bio-markers.

Analyzed using: cbioportal.org.

Oncomine Fusion assay genes profile in Pan-cancer data

A graph shows Oncomine Fusion assay genes profile in Pan-cancer data.

Multiple tumors such as Bone sarcoma, breast cancer, CRC, cholangiocarcinoma, gastric cancer, Head and neck cancer, melanoma, lung cancer, prostate cancer, salivary gland carcinoma, thyroid cancer, uterine sarcoma are showing fusion drivers in >2% of the cases, that can be detected by Oncomine focus assay.

Analyzed using: cbioportal.org.

Evidence based variant classification by Oncomine Reporter

The image of Evidence based variant classification by Oncomine Reporter.

Assay sensitivity and specificity

  • Can identify mutation with 5% variant allele frequency (5% mutant DNA, among 95% normal DNA).
  • LOD for RNA fusion is 255 copies of RNA.
  • RNA fusions and CNV changes detected by NGS has equal sensitivity to FISH.
  • Hence multiple testing is not required.
A graph showing Oncomine Assay sensitivity and specificity.

List of druggable targets

List of FDA approved drugs covered
Biomarker Drugs Disease
BRAF V600E; BRAF V600K Vemurafenib, Cobimetinib, Dabrafenib, Trametinib, Atezolizumab, Encorafenib Melanoma, NSCLC, CRC
ALK Fusion, EML4-ALK Crizotinib, Ceritinib, Alectinib, Brigatinib, Lorlatinib NSCLC
c-KIT Imatinib, Sunitinib, Regorafenib, Ripertinib GIST
EGFR Cetuximab, Mobocertinib, Afatinib, Gefitinib, Amivantamb, Osimertinib, Erlotinib Lung cancer
EGFR Panitumumab, Dacomitinib CRC
ERBB2 Fam-trastuzumab Deruxtecan-nxki NSCLC
ERBB2/HER2 amplification Trastuzumab, Pertuzumab, Ado-trastuzumab Emtansine Breast cancer, Gastric cancer
FGFR2-Fusions Pemigatinib, Infigratinib Cholangiocarcinoma
FGFR3 mutation/Fusion Erdafitinib Urothelial Cancer
KRAS Cetuximab, Panitumumab, Sotorasib CRC, NSCLC
NRAS Panitumumab CRC
MET, exon skipping Capmatinib NSCLC
NTRK1, NTRK2, NTRK3-fusions Larotrectinib, Entrectinib Pan solid tumors
PIK3CA Olaparib, Alpelisib Breast cancer, Pan solid tumors
RET-Fusions Pralsetinib, Selpercatinib NSCLC
RET-Fusions/mutation Selpercatinib Thyroid cancer
Ros1-fusions Entrectinib, Crizotinib NSCLC
Sample Type
FFPE Block or Fresh Tissue in ONCO-Bank
TAT
2 to 3 Weeks
Greams Road
044 43539444
PURASAIWALKKAM CENTRE
044 43539444
Central Pathology Lab
044 43539444
Central Genetic Lab
044 43539444
Become a PartnerFind My Tests
© 2024 Anderson Diagnostics & Labs. All rights are reserved.
HTML SitemapPrivacy PolicyCareers
Designed by
Digital SEO
magnifiercrosstext-align-justify